mTOR signaling and its roles in normal and abnormal brain development

Frontiers in Molecular Neuroscience

Volumn 7, Issue 1 APR, 2014, Pages

  Takei, Nobuyuki ^a   Nawa, Hiroyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Amino acids; BDNF; Brain malformation; CNS neurons; mTORC1 signaling; Protein synthesis; Translational control; TSC mTOR

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 1 RECEPTOR; CILIARY NEUROTROPHIC FACTOR; EPHRIN A1; FK 506 BINDING PROTEIN; GLUTAMIC ACID; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; PROTEIN KINASE B; REELIN; SEMAPHORIN 3A; SEROTONIN; SOMATOMEDIN BINDING PROTEIN; VASCULOTROPIN;

AUTOPHAGY; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM FUNCTION; ENZYME ACTIVATION; HUMAN; LIPOGENESIS; NERVE CELL GROWTH; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUBEROUS SCLEROSIS;

EID: 84899144736     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00028     Document Type: Review

References (125)

1. Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S., et al. (2006). Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25, 6361-6372. doi: 10.1038/sj.onc.1209882
2. Baybis, M., Yu, J., Lee, A., Golden, J. A., Weiner, H., McKhann, G. II, et al. (2004). mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann. Neurol. 56, 478-487. doi: 10.1002/ana.20211
3. Bentzinger, C. F., Romanino, K., Cloëtta, D., Lin, S., Mascarenhas, J. B., Oliveri, F., et al. (2008). Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab.8, 411-424. doi: 10.1016/j.cmet.2008.10.002
4. Bonfils, G., Jaquenoud, M., Bontron, S., Ostrowicz, C., Ungermann, C., and De Virgilio, C. (2012). Leucyl-tRNA synthetase controls TORC1 via the EGO complex. Mol. Cell 46, 105-110. doi: 10.1016/j.molcel.2012.02.009
5. Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D. A., Rozovsky, I., et al. (1997). Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278, 477-483. doi: 10.1126/science.278.5337.477
6. Brown, N. F., Stefanovic-Racic, M., Sipula, I. J., and Perdomo, G. (2007). The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes. Metabolism 56, 1500-1507. doi: 10.1016/j.metabol.2007.06.016
7. Campbell, D. S., and Holt, C. E. (2001). Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 32, 1013-1026. doi: 10.1016/S0896-6273(01)00551-7
8. Campbell, L. E., Wang, X., and Proud, C. G. (1999). Nutrients differentially regulate multiple translation factors and their control by insulin. Biochem. J. 344, 433-441. doi: 10.1042/0264-6021:3440433
9. Carroll, M., Dyer, J., and Sossin, W. S. (2006). Serotonin increases phosphorylation of synaptic 4EBP through TOR, but eukaryotic initiation factor 4E levels do not limit somatic cap-dependent translation in aplysia neurons. Mol. Cell. Biol. 26, 8586-8598. doi: 10.1128/MCB.00955-06
10. Carroll, M., Warren, O., Fan, X., and Sossin, W. S. (2004). 5-HT stimulates eEF2 dephosphorylation in a rapamycin-sensitive manner in Aplysia neurites. J. Neurochem. 90, 1464-1476. doi: 10.1111/j.1471-4159.2004.02634.x
11. Carson, R. P., Fu, C., Winzenburger, P., and Ess, K. C. (2013). Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex. Hum. Mol. Genet. 22, 140-152. doi: 10.1093/hmg/dds414
12. Casadio, A., Martin, K. C., Giustetto, M., Zhu, H., Chen, M., Bartsch, D., et al. (1999). A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell 99, 221-237. doi: 10.1016/S0092-8674(00)81653-0
13. Chenal, J., Pierre, K., and Pellerin, L. (2008). Insulin and IGF-1 enhance the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin pathway. Eur. J. Neurosci. 27, 53-65. doi: 10.1111/j.1460-9568.2007.05981.x
14. Choo, A. Y., and Blenis, J. (2009). Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle 8, 567-572. doi: 10.4161/cc.8.4.7659
15. Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F. R., Rosa, J. L., et al. (2006). TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J. Biol. Chem. 281, 8313-8316. doi: 10.1074/jbc.C500451200
16. Choo, A. Y., Roux, P. P., and Blenis, J. (2006). Mind the GAP: Wnt steps onto the mTORC1 train. Cell 126, 834-836. doi: 10.1016/j.cell.2006.08.025
17. Cloëtta, D., Thomanetz, V., Baranek, C., Lustenberger, R. M., Lin, S., Oliveri, F., et al. (2013). Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. J. Neurosci. 33, 7799-7810. doi: 10.1523/JNEUROSCI.3294-12.2013
18. Crino, P. B. (2013). Evolving neurobiology of tuberous sclerosis complex. Acta Neuropathol. 125, 317-332. doi: 10.1007/s00401-013-1085-x
19. Crino, P. B., Aronica, E., Baltuch, G., and Nathanson, K. L. (2010). Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology 74, 1716-1723. doi: 10.1212/WNL.0b013e3181e04325
20. Crino, P. B., Nathanson, K. L., and Henske, E. P. (2006). The tuberous sclerosis complex. N. Engl. J. Med. 355, 1345-1356. doi: 10.1056/NEJMra055323
21. Dibble, C. C., Elis, W., Menon, S., Qin, W., Klekota, J., Asara, J. M., et al. (2012). TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell 47, 535-546. doi: 10.1016/j.molcel.2012.06.009
22. Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., et al. (2010). Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171-183. doi: 10.1016/j.molcel.2010.06.022
23. Feliciano, D. M., Su, T., Lopez, J., Platel, J. C., and Bordey, A. (2011). Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J. Clin. Invest. 121, 1596-1607. doi: 10.1172/JCI44909
24. Gao, X., Zhang, Y., Arrazola, P., Hino, O., Kobayashi, T., Yeung, R. S., et al. (2002). Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 4, 699-704. doi: 10.1038/ncb847
25. Gong, R., Park, C. S., Abbassi, N. R., and Tang, S. J. (2006). Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons.J. Biol. Chem. 281, 18802-18815. doi: 10.1074/jbc.M512524200
26. Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., et al. (2006). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1. Dev. Cell 11, 859-871. doi: 10.1016/j.devcel.2006.10.007
27. Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., et al. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226. doi: 10.1016/j.molcel.2008.03.003
28. Hall, M. N. (2013). On mTOR nomenclature. Biochem. Soc. Trans. 41, 887-888. doi: 10.1042/BST20130092
29. Han, J. M., Jeong, S. J., Park, M. C., Kim, G., Kwon, N. H., Kim, H. K., et al. (2012). Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149, 410-424. doi: 10.1016/j.cell.2012.02.044
30. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., et al. (2002). Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189. doi: 10.1016/S0092-8674(02)00833-4
31. Hara, K., Yonezawa, K., Weng, Q. P., Kozlowski, M. T., Belham, C., and Avruch, J. (1998). Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273, 14484-14494. doi: 10.1074/jbc.273.23.14484
32. Hardt, M., Chantaravisoot, N., and Tamanoi, F. (2011). Activating mutations of TOR (target of rapamycin). Genes Cells 16, 141-151. doi: 10.1111/j.1365-2443.2010.01482.x
33. Harris, T. E., Chi, A., Shabanowitz, J., Hunt, D. F., Rhoads, R. E., and Lawrence, J. C. Jr. (2006). mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. EMBO J. 25, 1659-1668. doi: 10.1038/sj.emboj.7601047
34. Heitman, J., Movva, N. R., Hiestand, P. C., and Hall, M. N. (1991a). FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 88, 1948-1952. doi: 10.1073/pnas.88.5.1948
35. Heitman, J., Movva, N. R., and Hall, M. N. (1991b). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905-909. doi: 10.1126/science.1715094
36. Hentges, K. E., Sirry, B., Gingeras, A. C., Sarbassov, D., Sonenberg, N., Sabatini, D., et al. (2001). FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse. Proc. Natl. Acad. Sci. U.S.A. 98, 13796-13801. doi: 10.1073/pnas.241184198
37. Holz, M. K., Ballif, B. A., Gygi, S. P., and Blenis, J. (2005). mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123, 569-580. doi: 10.1016/j.cell.2005.10.024
38. Hou, L., and Klann, E. (2004). Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci.24, 6352-6361. doi: 10.1523/JNEUROSCI.0995-04.2004
39. Hu, J., Zacharek, S., He, Y. J., Lee, H., Shumway, S., Duronio, R. J., et al. (2008). WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase. Genes Dev. 22, 866-871. doi: 10.1101/gad.1624008
40. Huang, Y., Kang, B. N., Tian, J., Liu, Y., Luo, H. R., Hester, L., et al. (2007). The cationic amino acid transporters CAT1 and CAT3 mediate NMDA receptor activation-dependent changes in elaboration of neuronal processes via the mammalian target of rapamycin mTOR pathway. J. Neurosci. 27, 449-458. doi: 10.1523/JNEUROSCI.4489-06.2007
41. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280, 29060-29066. doi: 10.1074/jbc.M503824200
42. Inamura, N., Nawa, H., and Takei, N. (2005). Enhancement of translation elongation in neurons by brain-derived neurotrophic factor: implications for mammalian target of rapamycin signaling. J. Neurochem. 95, 1438-1445. doi: 10.1111/j.1471-4159.2005.03466.x
43. Inoki, K., Li, Y., Xu, T., and Guan, K. L. (2003a). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829-1834. doi: 10.1101/gad.1110003
44. Inoki, K., Zhu, T., and Guan, K. L. (2003b). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590. doi: 10.1016/S0092-8674(03)00929-2
45. Inoki, K., Li, Y., Zhu, T., Wu, J., and Guan, K. L. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648-657. doi: 10.1038/ncb839
46. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., et al. (2006). TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968. doi: 10.1016/j.cell.2006.06.055
47. Ishizuka, Y., Kakiya, N., Nawa, H., and Takei, N. (2008). Leucine induces phosphorylation and activation of p70S6K in cortical neurons via the system L amino acid transporter. J. Neurochem. 106, 934-942. doi: 10.1111/j.1471-4159.2008.05438.x
48. Ishizuka, Y., Kakiya, N., Witters, L. A., Oshiro, N., Shirao, T., Nawa, H., et al. (2013). AMP-activated protein kinase counteracts brain-derived neurotrophic factor-induced mammalian target of rapamycin complex 1 signaling in neurons. J. Neurochem. 127, 66-77. doi: 10.1111/jnc.12362
49. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., et al. (2004). Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128. doi: 10.1038/ncb1183
50. Jaworski, J., Spangler, S., Seeburg, D. P., Hoogenraad, C. C., and Sheng, M. (2005). Control of dendritic arborization by the phosphoinositide-3′-kinase-Akt-mammalian target of rapamycin pathway. J. Neurosci. 25, 11300-11312. doi: 10.1523/JNEUROSCI.2270-05.2005
51. Jossin, Y., and Goffinet, A. M. (2007). Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth. Mol. Cell. Biol. 27, 7113-7124. doi: 10.1128/MCB.00928-07
52. Kang, S. A., Pacold, M. E., Cervantes, C. L., Lim, D., Lou, H. J., Ottina, K., et al. (2013). mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 341, 12365-12366. doi: 10.1126/science.1236566
53. Kim, B. W., Choi, M., Kim, Y. S., Park, H., Lee, H. R., Yun, C. O., et al. (2008a). Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin. Cell. Signal. 20, 714-725. doi: 10.1016/j.cellsig.2007.12.009
54. Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P., and Guan, K. L. (2008b). Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935-945. doi: 10.1038/ncb1753
55. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., et al. (2002). mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175. doi: 10.1016/S0092-8674(02)00808-5
56. Kumar, V., Zhang, M. X., Swank, M. W., Kunz, J., and Wu, G. Y. (2005). Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J. Neurosci. 25, 11288-11299. doi: 10.1523/JNEUROSCI.2284-05.2005
57. Kwon, C. H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., et al. (2006). Pten regulates neuronal arborization and social interaction in mice. Neuron 50, 377-388. doi: 10.1016/j.neuron.2006.03.023
58. Laplante, M., and Sabatini, D. M. (2009). An emerging role of mTOR in lipid biosynthesis. Curr. Biol. 19, R1046-R1052. doi: 10.1016/j.cub.2009.09.058
59. Laplante, M., and Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell 149, 274-293. doi: 10.1016/j.cell.2012.03.017
60. Lee, C. C., Huang, C. C., Wu, M. Y., and Hsu, K. S. (2005). Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J. Biol. Chem. 280, 18543-18550. doi: 10.1074/jbc.M414112200
61. Lee, J. H., Huynh, M., Silhavy, J. L., Kim, S., Dixon-Salazar, T., Heiberg, A., et al. (2012). De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat. Genet. 44, 941-945. doi: 10.1038/ng.2329
62. Lenz, G., and Avruch, J. (2005). Glutamatergic regulation of the p70S6 kinase in primary mouse neurons. J. Biol. Chem. 280, 38121-38124. doi: 10.1074/jbc.C500363200
63. Lewin, G. R., and Barde, Y. A. (1996). Physiology of the neurotrophins. Annu. Rev. Neurosci. 19, 289-317. doi: 10.1146/annurev.ne.19.030196.001445
64. Li, Y., Inoki, K., Yeung, R., and Guan, K. L. (2002). Regulation of TSC2 by 14-3-3 binding. J. Biol. Chem. 277, 44593-44596. doi: 10.1074/jbc.C200510200
65. Liao, L., Pilotte, J., Xu, T., Wong, C. C., Edelman, G. M., Vanderklish, P., et al. (2007). BDNF induces widespread changes in synaptic protein content and up-regulates components of the translation machinery: an analysis using high-throughput proteomics. J. Proteome Res. 6, 1059-1071. doi: 10.1021/pr060358f
66. Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., and Avruch, J. (2005). Rheb binds and regulates the mTOR kinase. Curr. Biol. 15, 702-713. doi: 10.1016/j.cub.2005.02.053
67. Ma, L., Teruya-Feldstein, J., Bonner, P., Bernardi, R., Franz, D. N., Witte, D., et al. (2007). Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res. 67, 7106-7112. doi: 10.1158/0008-5472.CAN-06-4798
68. Magri, L., Cambiaghi, M., Cominelli, M., Alfaro-Cervello, C., Cursi, M., Pala, M., et al. (2011). Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell 9, 447-462. doi: 10.1016/j.stem.2011.09.008
69. Manadas, B., Santos, A. R., Szabadfi, K., Gomes, J. R., Garbis, S. D., Fountoulakis, M., et al. (2009). BDNF-induced changes in the expression of the translation machinery in hippocampal neurons: protein levels and dendritic mRNA. J. Proteome Res. 8, 4536-4552. doi: 10.1021/pr900366x
70. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., and Cantley, L. C. (2002). Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 10, 151-162. doi: 10.1016/S1097-2765(02)00568-3
71. McAllister, A. K., Lo, D. C., and Katz, L. C. (1995). Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15, 791-803. doi: 10.1016/0896-6273(95)90171-X
72. Miyata, H., Chiang, A. C., and Vinters, H. V. (2004). Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann. Neurol. 56, 510-519. doi: 10.1002/ana.20234
73. Morgane, P. J., Austin-LaFrance, R., Bronzino, J., Tonkiss, J., Díaz-Cintra, S., Cintra, L., et al. (1993). Prenatal malnutrition and development of the brain. Neurosci. Biobehav. Rev. 17, 91-128. doi: 10.1016/S0149-7634(05)80234-9
74. Murakami, M., Ichisaka, T., Maeda, M., Oshiro, N., Hara, K., Edenhofer, F., et al. (2004). mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol. Cell. Biol. 24, 6710-6718. doi: 10.1128/MCB.24.15.6710-6718.2004
75. Nakashima, A., Yoshino, K., Miyamoto, T., Eguchi, S., Oshiro, N., Kikkawa, U., et al. (2007). Identification of TBC7 having TBC domain as a novel binding protein to TSC1-TSC2 complex. Biochem. Biophys. Res. Commun. 361, 218-223. doi: 10.1016/j.bbrc.2007.07.011
76. Nawa, H., and Takei, N. (2001). BDNF as an anterophin; a novel neurotrophic relationship between brain neurons. Trends Neurosci. 24, 683-684. doi: 10.1016/S0166-2236(00)01955-X
77. Nellist, M., Goedbloed, M. A., de Winter, C., Verhaaf, B., Jankie, A., Reuser, A. J., et al. (2002). Identification and characterization of the interaction between tuberin and 14-3-3π{variant}. J. Biol. Chem. 277, 39417-39424. doi: 10.1074/jbc.M204802200
78. Nie, D., Di Nardo, A., Han, J. M., Baharanyi, H., Kramvis, I., Huynh, T., et al. (2010). Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat. Neurosci. 13, 163-167. doi: 10.1038/nn.2477
79. Nojima, H., Tokunaga, C., Eguchi, S., Oshiro, N., Hidayat, S., Yoshino, K., et al. (2003). The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J. Biol. Chem. 278, 15461-15464. doi: 10.1074/jbc.C200665200
80. Ohne, Y., Takahara, T., Hatakeyama, R., Matsuzaki, T., Noda, M., Mizushima, N., et al. (2008). Isolation of hyperactive mutants of mammalian target of rapamycin. J. Biol. Chem. 283, 31861-31870. doi: 10.1074/jbc.M801546200
81. Oshiro, N., Takahashi, R., Yoshino, K., Tanimura, K., Nakashima, A., Eguchi, S., et al. (2007). The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J. Biol. Chem. 282, 20329-20339. doi: 10.1074/jbc.M702636200
82. Page, G., Khidir, F. A., Pain, S., Barrier, L., Fauconneau, B., Guillard, O., et al. (2006). Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes. Neurochem. Int. 49, 413-421. doi: 10.1016/j.neuint.2006.01.020
83. Peng, T., Golub, T. R., and Sabatini, D. M. (2002). The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol. 22, 5575-5584. doi: 10.1128/MCB.22.15.5575-5584.2002
84. Piper, M., Anderson, R., Dwivedy, A., Weinl, C., van Horck, F., Leung, K. M., et al. (2006). Signaling mechanisms underlying Slit2-induced collapse of Xenopus retinal growth cones. Neuron 49, 215-228. doi: 10.1016/j.neuron.2005.12.008
85. Poduri, A., Evrony, G. D., Cai, X., Elhosary, P. C., Beroukhim, R., Lehtinen, M. K., et al. (2012). Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74, 41-48. doi: 10.1016/j.neuron.2012.03.010
86. Polakiewicz, R. D., Schieferl, S. M., Gingras, A. C., Sonenberg, N., and Comb, M. J. (1998). mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J. Biol. Chem. 273, 23534-23541. doi: 10.1074/jbc.273.36.23534
87. Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., et al. (2008). SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224-236. doi: 10.1016/j.cmet.2008.07.007
88. Prabowo, A. S., Anink, J. J., Lammens, M., Nellist, M., van den Ouweland, A. M., Adle-Biassette, H., et al. (2013). Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol. 23, 45-59. doi: 10.1111/j.1750-3639.2012.00616.x
89. Puighermanal, E., Marsicano, G., Busquets-Garcia, A., Lutz, B., Maldonado, R., and Ozaita, A. (2009). Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 1152-1158. doi: 10.1038/nn.2369
90. Qin, W., Chan, J. A., Vinters, H. V., Mathern, G. W., Franz, D. N., Taillon, B. E., et al. (2010). Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Brain Pathol. 20, 1096-1105. doi: 10.1111/j.1750-3639.2010.00416.x
91. Quevedo, C., Salinas, M., and Alcázar, A. (2002). Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells. Biochem. Biophys. Res. Commun. 291, 560-566. doi: 10.1006/bbrc.2002.6479
92. Raught, B., Gingras, A. C., Gygi, S. P., Imataka, H., Morino, S., Gradi, A., et al. (2000). Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J. 19, 434-444. doi: 10.1093/emboj/19.3.434
93. Raught, B., Peiretti, F., Gingras, A. C., Livingstone, M., Shahbazian, D., Mayeur, G. L., et al. (2004). Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J. 23, 1761-1769. doi: 10.1038/sj.emboj.7600193
94. Ruvinsky, I., and Meyuhas, O. (2006). Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 31, 342-348. doi: 10.1016/j.tibs.2006.04.003
95. Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., et al. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501. doi: 10.1126/science.1157535
96. Sarbassov, D. D., Ali, S. M., Kim, D. H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., et al. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302. doi: 10.1016/j.cub.2004.06.054
97. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., et al. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168. doi: 10.1016/j.molcel.2006.03.029
98. Schalm, S. S., and Blenis, J. (2002). Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12, 632-639. doi: 10.1016/S0960-9822(02)00762-5
99. Schreiber, S. L. (1991). Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science251, 283-287. doi: 10.1126/science.1702904
100. Segev, N., and Hay, N. (2012). Hijacking leucyl-tRNA synthetase for amino acid-dependent regulation of TORC1. Mol. Cell 46, 4-6. doi: 10.1016/j.molcel.2012.03.028
101. Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., et al. (2006). The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25, 2781-2791. doi: 10.1038/sj.emboj.7601166
102. Shima, H., Pende, M., Chen, Y., Fumagalli, S., Thomas, G., and Kozma, S. C. (1998). Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17, 6649-6659. doi: 10.1093/emboj/17.22.6649
103. Shiota, C., Woo, J. T., Lindner, J., Shelton, K. D., and Magnuson, M. A. (2006). Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell 11, 583-589. doi: 10.1016/j.devcel.2006.08.013
104. Shor, B., Zhang, W. G., Toral-Barza, L., Lucas, J., Abraham, R. T., Gibbons, J. J., et al. (2008). A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis. Cancer Res. 68, 2934-2943. doi: 10.1158/0008-5472.CAN-07-6487
105. Shumway, S. D., Li, Y., and Xiong, Y. (2003). 14-3-3β binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin. J. Biol. Chem. 278, 2089-2092. doi: 10.1074/jbc.C200499200
106. Suzuki, S., Kiyosue, K., Hazama, S., Ogura, A., Kashihara, M., Hara, T., et al. (2007). Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J. Neurosci. 27, 6417-6427. doi: 10.1523/JNEUROSCI.0690-07.2007
107. Takei, N., Inamura, N., Kawamura, M., Namba, H., Hara, K., Yonezawa, K., et al. (2004). Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J. Neurosci. 24, 9760-9769. doi: 10.1523/JNEUROSCI.1427-04.2004
108. Takei, N., Kawamura, M., Hara, K., Yonezawa, K., and Nawa, H. (2001). Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes: comparison with the effects of insulin. J. Biol. Chem. 276, 42818-42825. doi: 10.1074/jbc.M103237200
109. Takei, N., Kawamura, M., Ishizuka, Y., Kakiya, N., Inamura, N., Namba, H., et al. (2009). Brain-derived neurotrophic factor enhances the basal rate of protein synthesis by increasing active eukaryotic elongation factor 2 levels and promoting translation elongation in cortical neurons. J. Biol. Chem. 284, 26340-26348. doi: 10.1074/jbc.M109.023010
110. Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., and Blenis, J. (2002). Tuberous sclerosis complex-1 and-2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. U.S.A. 99, 13571-13576. doi: 10.1073/pnas.202476899
111. Thomanetz, V., Angliker, N., Cloëtta, D., Lustenberger, R. M., Schweighauser, M., Oliveri, F., et al. (2013). Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J. Cell Biol. 201, 293-308. doi: 10.1083/jcb.201205030
112. Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., and Sabatini, D. M. (2012). A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109-113. doi: 10.1038/nature11083
113. Tsai, V., Parker, W. E., Orlova, K. A., Baybis, M., Chi, A. W., Berg, B. D., et al. (2012). Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb. Cortex 24, 315-327. doi: 10.1093/cercor/bhs310
114. Urano, J., Sato, T., Matsuo, T., Otsubo, Y., Yamamoto, M., and Tamanoi, F. (2007). Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 104, 3514-3519. doi: 10.1073/pnas.0608510104
115. van Gorp, A. G., van der Vos, K. E., Brenkman, A. B., Bremer, A., van den Broek, N., Zwartkruis, F., et al. (2009). AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B. Oncogene 28, 95-106. doi: 10.1038/onc.2008.367
116. Vézina, C., Kudelski, A., and Sehgal, S. N. (1975). Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. (Tokyo) 28, 721-726. doi: 10.7164/antibiotics.28.721
117. Wang, X., Li, W., Williams, M., Terada, N., Alessi, D. R., and Proud, C. G. (2001). Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase. EMBO J. 20, 4370-4379. doi: 10.1093/emboj/20.16.4370
118. Way, S. W., McKenna, J. III, Mietzsch, U., Reith, R. M., Wu, H. C., and Gambello, M. J. (2009). Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum. Mol. Genet. 18, 1252-1265. doi: 10.1093/hmg/ddp025
119. Witters, L. A., Kemp, B. E., and Means, A. R. (2006). Chutes and Ladders: the search for protein kinases that act on AMPK. Trends Biochem. Sci. 31, 13-16. doi: 10.1016/j.tibs.2005.11.009
120. Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G., Neumann, D., et al. (2003). LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004-2008. doi: 10.1016/j.cub.2003.10.031
121. Yamagata, K., Sanders, L. K., Kaufmann, W. E., Yee, W., Barnes, C. A., Nathans, D., et al. (1994). rheb, a growth factor-and synaptic activity-regulated gene, encodes a novel Ras-related protein. J. Biol. Chem. 269, 16333-16339.
122. Yamauchi, Y., Furukawa, K., Hamamura, K., and Furukawa, K. (2011). Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen. Cancer Res. 71, 4989-4997. doi: 10.1158/0008-5472.CAN-10-4108
123. Yang, H., Rudge, D. G., Koos, J. D., Vaidialingam, B., Yang, H. J., and Pavletich, N. P. (2013). mTOR kinase structure, mechanism and regulation. Nature 497, 217-223. doi: 10.1038/nature12122
124. + current through the Akt/mTOR pathway. Am. J. Physiol. Cell Physiol. 305, C197-C206. doi: 10.1152/ajpcell.00041.2013
125. Yokogami, K., Wakisaka, S., Avruch, J., and Reeves, S. A. (2000). Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10, 47-50. doi: 10.1016/S0960-9822(99)00268-7